CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 38 enrolled
Drug / intervention
Alivecor monitor and 14 day event monitordevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02005172
NCT02005172N/ACompleted
CompareCT.gov

Validation of an iPhone-based Event Recorder for Arrhythmia Detection

University at Buffalo·interventional·Posted Dec 9, 2013·Updated May 25, 2023

In Brief

A clinical study evaluating Alivecor monitor and 14 day event monitor for Arrhythmia, Palpitations, Lightheadedness. Completed, enrolled 38 participants across 1 site.

Detailed Summary

In this study, we will evaluate the diagnostic yield of the new AliveCor device versus a 14 day event monitor with the use of both devices simultaneously. We will also examine by means of a questionnaire the compliance, ease of use and patient satisfaction for each device. Hypothesis: 1. The AliveCor monitor will be non-inferior to the 14 day event monitor with respect to diagnosis of the arrhythmia responsible for a patient's symptoms. 2. The AliveCor monitor will have better compliance and acceptability compared to the 14 day event monitor, and thus there will be a greater number of days with recordings from the AliveCor monitor.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsArrhythmia, Palpitations, Lightheadedness
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedDec 9, 2013
Enrollment StartNov 1, 2013
Primary CompletionMar 1, 2016
Study CompletionMay 1, 2016
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 12.6 years ago

Interventions

Alivecor monitor and 14 day event monitordevice

Alivecor monitor and 14 day event monitor